Related Experiment Video
Updated: Dec 25, 2025

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
Aptamer-guided extracellular vesicle theranostics in oncology
Phuong H-L Tran1, Dongxi Xiang2, Tuong N-G Nguyen1
1School of Medicine and Centre for Molecular and Medical Research, Deakin University, Waurn Ponds, Victoria, Australia.
Exosomes, tiny vesicles, show promise in cancer theranostics as diagnostic tools and drug delivery systems. Aptamers enhance exosome targeting for improved precision medicine applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Biology
Background:
- Exosomes are nanosized vesicles involved in intercellular communication and disease pathogenesis.
- Their cargo and interactions with cells make them crucial in homeostasis and disease.
- Exosome-based liquid biopsies offer a new frontier in precision medicine for early disease detection.
Purpose of the Study:
- To review current research on exosomes and aptamers in cancer theranostics.
- To highlight advances in exosome-based liquid biopsy and drug delivery.
- To discuss the clinical translation of these technologies.
Main Methods:
- Literature review of exosomes and aptamers in cancer theranostics.
- Analysis of exosome properties for diagnostic and therapeutic applications.
- Exploration of aptamer conjugation for targeted drug delivery.
Main Results:
- Exosomes serve as effective drug delivery vehicles due to their size and homing effects.
- Aptamers enhance exosome targeting and can act as diagnostic/therapeutic agents.
- Combined exosome-aptamer systems show significant potential in cancer theranostics.
Conclusions:
- Exosomes and aptamers represent a powerful combination for advancing cancer theranostics.
- Further research and clinical translation are needed to fully realize their potential.
- These technologies pave the way for next-generation precision medicine.
More Related Videos
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024